| Reduced-intensity conditioning and dual T lymphocyte suppression with antithymocyte globulin and post-transplant cyclophosphamide as graft-versus-host disease prophylaxis in … AD Law, MQ Salas, W Lam, FV Michelis, S Thyagu, JH Lipton, R Kumar, ... Biology of Blood and Marrow Transplantation 24 (11), 2259-2264, 2018 | 78 | 2018 |
| Critical illness in patients with hematologic malignancy: a population-based cohort study BL Ferreyro, DC Scales, H Wunsch, MC Cheung, V Gupta, R Saskin, ... Intensive Care Medicine 47, 1104-1114, 2021 | 56 | 2021 |
| Efficacy and safety of empagliflozin in glycogen storage disease type Ib: Data from an international questionnaire SC Grünert, TGJ Derks, K Adrian, K Al-Thihli, D Ballhausen, J Bidiuk, ... Genetics in medicine 24 (8), 1781-1788, 2022 | 46 | 2022 |
| Efficacy of cidofovir in treatment of BK virus–induced hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients EA Coomes, A Wolfe, FV Michelis, S Thyagu, A Viswabandya, JH Lipton, ... Biology of Blood and Marrow Transplantation 24 (9), 1901-1905, 2018 | 43 | 2018 |
| Prolonged granulocyte colony stimulating factor use in glycogen storage disease type 1b associated with acute myeloid leukemia and with shortened telomere length AM Li, S Thyagu, D Maze, R Schreiber, S Sirrs, S Stockler-Ipsiroglu, ... Pediatric Hematology and Oncology 35 (1), 45-51, 2018 | 40 | 2018 |
| Treatment of Philadelphia chromosome‐positive acute lymphoblastic leukaemia with imatinib combined with a paediatric‐based protocol S Thyagu, MD Minden, V Gupta, KWL Yee, AD Schimmer, AC Schuh, ... British journal of haematology 158 (4), 506-514, 2012 | 40 | 2012 |
| Low rates of acute and chronic GVHD with ATG and PTCy in matched and mismatched unrelated donor peripheral blood stem cell transplants S Prem, EG Atenafu, Z Al‐Shaibani, D Loach, A Law, W Lam, FV Michelis, ... European Journal of Haematology 102 (6), 486-493, 2019 | 37 | 2019 |
| Incidence and risk factors for nontuberculous mycobacterial infection after allogeneic hematopoietic cell transplantation J Beswick, E Shin, FV Michelis, S Thyagu, A Viswabandya, JH Lipton, ... Biology of Blood and Marrow Transplantation 24 (2), 366-372, 2018 | 36 | 2018 |
| Reduction of severe acute graft-versus-host disease using a combination of pre transplant anti-thymocyte globulin and post-transplant cyclophosphamide in matched unrelated … U Deotare, EG Atenafu, D Loach, FV Michelis, D Kim, S Thyagu, JH Lipton, ... Bone Marrow Transplantation 53 (3), 361-365, 2018 | 32 | 2018 |
| Safety and efficacy of haploidentical peripheral blood stem cell transplantation for myeloid malignancies using post-transplantation cyclophosphamide and anti-thymocyte … MQ Salas, AD Law, W Lam, Z Al-Shaibani, D Loach, DDH Kim, ... Clinical Hematology International 1 (2), 105-113, 2019 | 26 | 2019 |
| Extramedullary disease at diagnosis of AML does not influence outcome of patients undergoing allogeneic hematopoietic cell transplant in CR 1 C Bourlon, JH Lipton, U Deotare, V Gupta, DD Kim, J Kuruvilla, ... European Journal of Haematology 99 (3), 234-239, 2017 | 23 | 2017 |
| Outcome following second allogeneic hematopoietic cell transplantation: A single‐center experience HA Aljasem, HA Messner, JH Lipton, DDH Kim, A Viswabandya, ... European Journal of Haematology 100 (3), 308-314, 2018 | 18 | 2018 |
| My jamais vu in post allogeneic hematopoietic cell transplant: a review on secondary hemophagocytosis in adults RM Alblooshi, U Deotare, FV Michelis, S Thyagu, D Kim, JH Lipton, ... Bone Marrow Transplantation 55 (5), 867-872, 2020 | 16 | 2020 |
| Quality of life following completion of treatment for adult acute lymphoblastic leukemia with a pediatric-based protocol E Liew, S Thyagu, EG Atenafu, SMH Alibhai, JM Brandwein Leukemia Research 37 (12), 1632-1635, 2013 | 13 | 2013 |
| Characteristics, treatment and outcomes of nontuberculous mycobacterial pulmonary disease after allogeneic haematopoietic stem cell transplant T Hirama, SK Brode, J Beswick, AD Law, W Lam, FV Michelis, S Thyagu, ... European Respiratory Journal 51 (5), 2018 | 12 | 2018 |
| Long-term survival and functional outcomes of critically ill patients with hematologic malignancies: a Canadian multicenter prospective study L Munshi, G Dumas, B Rochwerg, F Shoukat, M Detsky, DA Fergusson, ... Intensive Care Medicine 50 (4), 561-572, 2024 | 11 | 2024 |
| Efficacy and cost analysis of eltrombopag in thrombocytopenia and poor graft function post allogeneic hematopoietic cell transplantation RV Nampoothiri, L Ho, C McEwan, I Pasic, W Lam, AD Law, FV Michelis, ... Bone Marrow Transplantation 56 (10), 2471-2476, 2021 | 11 | 2021 |
| Influence of FLT3‐ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML I Pasic, W Da'na, W Lam, A Law, JH Lipton, A Viswabandya, DD Kim, ... European journal of haematology 102 (4), 368-374, 2019 | 10 | 2019 |
| Fludarabine and busulfan plus low-dose TBI as reduced intensity conditioning in older patients undergoing allogeneic hematopoietic cell transplant for myeloid malignancies MMI Khalil, HA Messner, JH Lipton, DD Kim, A Viswabandya, S Thyagu, ... Annals of hematology 97, 1975-1985, 2018 | 9 | 2018 |
| Perspectives on advance care planning for patients with hematologic malignancy: an international clinician questionnaire J Spring, J McKinlay, K Puxty, V Metaxa, M Detsky, S Mehta, S Thyagu, ... Annals of the American Thoracic Society 18 (9), 1533-1539, 2021 | 7 | 2021 |
